Safety and Tolerability Study of the VAC ∆6 Vaccine in Volunteers Aged 18-40 Years
Conditions: Smallpox; Monkeypox; Cowpox; Vaccinia Virus Infection Interventions: Biological: VAC∆6 vaccine - оnce at a dose of 10⁶ PFU; Biological: VAC∆6 vaccine - once at a dose of 10⁷ PFU; Biological: VAC∆6 vaccine - twice at a dose of 10⁶ PFU; Biological: Live smallpox vaccine (Smallpox vaccine) + The OspaVir® inactivated smallpox vaccine Sponsor: Federal Budgetary Research Institution State Research Center of Virology and Biotechnology " Vector " Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Monkeypox | Research | Smallpox | Smallpox Vaccine | Study | Vaccines | Virology